Hackensack Medical Center

Hackensack, New Jersey 07601

3 studies enrolling now · 18 studies all time

What they study most

Acute Myeloid Leukemia, Alzheimer Disease, Anti-coagulation Therapy, Atrial Fibrillation, B Cell Lymphoma, B Cell Non-Hodgkin's Lymphoma, COVID-19, Cervical Cancer, Chronic Myelomonocytic Leukemia, Chronic Total Occlusion of Coronary Artery, Coronary Artery Disease, Coronary Artery Restenosis

Studies at this site

• Gene Therapy for HER-Positive Cancer (SENTRY-HER2) — Recruiting now
• Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease — Recruiting now
• A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose) — Enrolling by invitation
• BOLT: Study of the Indigo® Aspiration System When Used in Patients With Deep Vein Thrombosis — Running, not enrolling
• Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial — Running, not enrolling
• Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma — Running, not enrolling
• Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer — Running, not enrolling
• CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER) — Status unconfirmed
• XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort — Completed
• A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies — Completed
• Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's Lymphoma — Stopped early
• Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment — Completed
• A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies — Completed
• Door To Unloading With IMPELLA CP System in Acute Myocardial Infarction - Safety and Feasibility Study — Completed
• Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN) — Paused
• SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS) — Completed
• A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes. — Completed
• Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures — Completed